Sapphire Medical Clinic announces global partnership with Australian-based Emyria’s Emerald Clinics
22/10/2020
Sapphire Medical Clinics is pleased to announce a global partnership with Emyria Limited (ASX: EMD), a company that manages an Australia-wide clinical service for
Real World Data & Patient Registries
20/10/2020
Medical cannabis researchers are still playing catchup as significant barriers and challenges to clinical research still need to be overcome
The Sapphire Institute for Medical Cannabis Education hosts its first webinar for patients ‘Treatment with a Medical Cannabis clinic’
25/09/2020
Industry experts discuss the practicalities and answer common patient questions about treatment with medical cannabis. There remains misconceptions about the
Sapphire Medical Foundation Funds Treatment for First Medical Cannabis Patient for One Year and appoints Baroness Molly Meacher as Chair of Trustees
26/07/2020
Today, and 2 years following the rescheduling of cannabis-based medicinal products in the UK, Sapphire Medical Foundation announced its first
UK Medical Cannabis Registry leveraging Real World Evidence data collection to decrease costs of access to medical cannabis for patients
17/06/2020
Sapphire Medical Clinics, the first specialised medical cannabis clinic approved to see patients by the Care Quality Commission, has today launched a ground-breaking initiative
